Related Experiment Video
Updated: Jul 21, 2025

Tumor Allotransplantation in Drosophila melanogaster with a Programmable Auto-Nanoliter Injector
Published on: February 2, 2021
Phosphorylated nuclear DICER1 promotes open chromatin state and lineage plasticity of AT2 tumor cells in lung
Raisa A Reyes-Castro1,2,3, Shin-Yu Chen1, Jacob Seemann1
1Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Abstract:
KRAS/ERK pathway phosphorylates DICER1, causing its nuclear translocation, and phosphomimetic Dicer1 contributes to tumorigenesis in mice. Mechanisms through which phospho-DICER1 regulates tumor progression remain undefined. While DICER1 canonically regulates microRNAs (miRNA) and epithelial-to-mesenchymal transition (EMT), we found that phosphorylated nuclear DICER1 (phospho-nuclear DICER1) promotes late-stage tumor progression in mice with oncogenic Kras, independent of miRNAs and EMT. Instead, we observe that the murine AT2 tumor cells exhibit altered chromatin compaction, and cells from disorganized advanced tumors, but not localized tumors, express gastric genes. Collectively, this results in subpopulations of tumor cells transitioning from a restricted alveolar to a broader endodermal lineage state. In human LUADs, we observed expression of phospho-nuclear DICER1 in advanced tumors together with the expression of gastric genes. We define a multimeric chromatin-DICER1 complex composed of the Mediator complex subunit 12, CBX1, MACROH2A.1, and transcriptional regulators supporting the model that phospho-nuclear DICER1 leads to lineage reprogramming of AT2 tumor cells to mediate lung cancer progression.
Insights
Phosphorylated DICER1 in the nucleus drives advanced lung cancer progression in mice, independent of microRNAs and EMT. This nuclear DICER1 reprograms tumor cells by altering chromatin, promoting a lineage shift that contributes to tumorigenesis.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- The KRAS/ERK pathway influences DICER1 phosphorylation and nuclear translocation, contributing to tumorigenesis.
- The precise mechanisms by which phosphorylated DICER1 (phospho-DICER1) drives tumor progression are not fully understood.
- DICER1's canonical roles involve microRNA (miRNA) regulation and epithelial-to-mesenchymal transition (EMT).
Purpose of the Study:
- To investigate the role of phospho-nuclear DICER1 in late-stage lung tumor progression.
- To elucidate the mechanisms by which phospho-nuclear DICER1 promotes cancer, independent of canonical miRNA and EMT pathways.
- To identify the molecular components and cellular processes involved in phospho-nuclear DICER1-mediated lung cancer progression.
Main Methods:
- Utilized a mouse model with oncogenic Kras to study lung tumor progression.
- Analyzed chromatin compaction and gene expression in murine AT2 tumor cells.
- Investigated the expression of phospho-nuclear DICER1 and gastric genes in human lung adenocarcinoma (LUAD) samples.
- Characterized a multimeric chromatin-DICER1 complex involving Mediator complex subunit 12, CBX1, and MACROH2A.1.
Main Results:
- Phospho-nuclear DICER1 promotes late-stage tumor progression in a Kras-driven mouse model, independent of miRNAs and EMT.
- Altered chromatin compaction and expression of gastric genes were observed in advanced murine lung tumors.
- Tumor cells exhibited a lineage transition from alveolar to endodermal states.
- Human LUADs with advanced disease showed co-expression of phospho-nuclear DICER1 and gastric genes.
Conclusions:
- Phospho-nuclear DICER1 drives lung cancer progression through lineage reprogramming of AT2 tumor cells.
- This reprogramming involves altered chromatin structure and the formation of a chromatin-DICER1 complex.
- The findings reveal a novel, non-canonical mechanism for DICER1 in mediating lung cancer progression and suggest potential therapeutic targets.
Related Concept Videos
TGF - β Signaling Pathway
Abnormal Proliferation
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
PI3K/mTOR/AKT Signaling Pathway
Canonical Wnt Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

